CerilliantLog In | My Cart (0)Cerilliant ISO
Cerilliant Introduces 25-Hydroxy Vitamin D3 Certified Reference Solution
In April, 2009, Cerilliant introduced the first certified reference solution of 25-Hydroxy Vitamin D3 (H-072). 25-Hydroxy Vitamin D3 is a major intermediate in the conversion of Vitamin D3 or Cholecalciferol to 1,25-Dihydroxy Vitamin D, the biologically active form of Vitamin D. Vitamin D nutritional status is often determined by clinical or diagnostic testing of 25-Hydroxy Vitamin D (calcidiol) levels in blood.

Vitamin D is well known as a hormone involved in mineral metabolism and bone growth. Classic manifestations of Vitamin D deficiency include rickets in children and osteomalacia in adults. Recent studies on Vitamin D deficiency have highlighted potential associations with hyperglycemia, insulin resistance, hypertension, and heart disease (http://www.sciencedaily.com/releases/2009/01/090112121821.htm). Other emerging research has implicated Vitamin D deficiency as a potential cause of increased risk of metabolic syndrome in teenagers (http://www.sciencedaily.com/releases/2009/03/090311153406.htm), a greater risk of age-related cognitive decline (http://www.naturalnews.com/025807.html), and higher percentages of body and visceral fat in adolescents (http://www.sciencedaily.com/releases/2009/03/090312140905.htm).

Cerilliant Certified Vitamin Reference Solutions

Return to Article List


© 2010 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Home | About Us | Quality | Capabilities | Products | News/Events | Contact | Sitemap | Privacy Policy